Table 3.
The association of device-measured and self-reported moderate-to-vigorous physical activity (MVPA) and device-measured sedentary time with health-related quality of life (HRQoL)
| Global health status | Physical functioning | Role functioning | Emotional functioning | Cognitive functioning | Social functioning | Summary score | Fatigue | |
|---|---|---|---|---|---|---|---|---|
| β (95% CI) | β (95% CI) | β (95% CI) | β (95% CI) | β (95% CI) | β (95% CI) | β (95% CI) | β (95% CI) | |
| Device-measured MVPA in quartiles (h/week)a,b | ||||||||
| 0–2.7 | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref |
| 2.8–4.2 | 7.7 (2.9, 12.5)* | 7.6 (3.9, 11.2)* | 8.2 (1.0, 15.5)* | 0.2 (− 5.6, 6.0) | − 0.8 (− 7.2, 5.7) | 2.6 (− 4.1, 9.3) | 2.8 (− 0.5, 6.1) | − 5.9 (− 12.4, 0.6) |
| 4.2–6.7 | 5.9 (0.8, 11.0)* | 5.8 (1.9, 9.6)* | 9.3 (1.6, 17.0)* | 0.2 (− 5.9, 6.3) | − 0.6 (− 7.5, 6.2) | 1.9 (− 5.1, 8.9) | 3.7 (0.2, 7.1)* | − 7.8 (− 14.6, − 0.9)* |
| ≥ 6.7 | 10.2 (5.1, 15.3)* | 7.7 (3.8, 11.6)* | 12.4 (4.7, 20.2)* | 1.7 (− 4.5, 7.9) | 0.6 (− 6.3, 7.5) | 7.3 (0.2, 14.4)* | 4.6 (1.1, 8.1)* | − 11.2 (− 18.1, − 4.2)* |
| p-trend | 0.001 | 0.001 | 0.003 | 0.60 | 0.83 | 0.06 | 0.01 | 0.002 |
| Device-measured MVPA continuous (h/week)a,b | ||||||||
| 1 unit increase | 1.1 (0.4, 1.7)* | 0.7 (0.2, 1.2)* | 1.3 (0.3, 2.2)* | 0.2 (− 0.5, 1.0) | − 0.1 (− 0.9, 0.8) | 0.8 (− 0.1, 1.6) | 0.5 (0.0, 0.9)* | − 1.3 (− 2.2, − 0.5)* |
| Device-measured MVPA in categories of WCRF/AICR recommendations (min/week)a,b,c | ||||||||
| < 150 | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref |
| ≥ 150 | 7.9 (3.6, 12.3)* | 8.0 (4.7 (11.3)* | 11.0 (4.5, 17.5)* | 0.5 (− 4.8, 5.7) | − 0.0 (− 5.8, 5.8) | 3.9 (− 2.1, 9.9) | 3.6 (0.6, 6.5)* | − 7.5 (− 13.4, − 1.6)* |
| Self-reported MVPA in quartiles (h/week)a | ||||||||
| 0–4.8 | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref |
| 5.0–9.5 | 2.5 (− 2.1, 7.1) | 5.5 (2.0, 9.0)* | 7.8 (0.9, 14.7)* | 0.4 (− 5.1, 5.8) | 0.4 (− 5.7, 6.5) | 3.3 (− 3.1, 9.6) | 1.3 (− 1.8, 4.5) | − 5.8 (− 12.0, 0.3) |
| 9.5–16.8 | 6.6 (1.8, 11.3)* | 7.6 (4.0, 11.2)* | 9.0 (1.9, 16.1)* | 0.5 (− 5.1, 6.2) | 0.7 (− 5.6, 7.0) | 3.6 (− 2.9, 10.1) | 2.5 (− 0.7, 5.7) | − 6.2 (− 12.6, 0.1) |
| ≥ 17.0 | 5.2 (0.5, 10.0)* | 8.4 (4.8, 11.9)* | 9.4 (2.4, 16.5)* | − 1.8 (− 7.4, 3.8) | 1.6 (− 4.7, 7.8) | 4.9 (− 1.5, 11.4) | 2.3 (− 0.9, 5.5) | − 5.8 (− 12.2, 0.5) |
| p-trend | 0.01 | < 0.001 | 0.01 | 0.55 | 0.61 | 0.15 | 0.12 | 0.09 |
| Self-reported MVPA continuous (h/week)a | ||||||||
| 1 unit increase | 0.1 (− 0.0, 0.3) | 0.2 (0.1, 0.3)* | 0.3 (0.1, 0.5)* | − 0.1 (− 0.3, 0.1) | 0.0 (− 0.2, 0.2) | 0.1 (− 0.1, 0.3) | 0.1 (− 0.0, 0.2) | − 0.1 (− 0.3, 0.1) |
| Self-reported MVPA in categories of WCRF/AICR recommendations (min/week)a,d | ||||||||
| < 150 | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref |
| ≥ 150 | 2.8 (− 2.4, 8.0) | 4.4 (0.4, 8.3)* | 4.9 (− 2.9, 12.6) | − 2.3 (− 8.4, 3.8) | − 1.2 (− 8.0, 5.6) | − 1.4 (− 8.5, 5.6) | 0.2 (− 3.3, 3.7) | − 2.3 (− 9.3, 4.6) |
| Device-measured sedentary time in quartiles (h/day)a,e | ||||||||
| ≥ 11.4 | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref |
| 10.2–11.4 | − 1.4 (− 6.1, 3.3) | 0.2 (− 3.4, 3.7) | − 6.1 (− 13.1, 0.9) | − 4.0 (− 9.6, 1.6) | − 5.7 (− 11.9, 0.5) | − 5.8 (− 12.3, 0.6) | − 1.9 (− 5.1, 1.3) | 4.4 (− 1.9, 10.6) |
| 8.8–10.2 | 0.8 (− 3.9, 5.6) | 3.8 (0.2, 7.4)* | 0.7 (− 6.4, 7.8) | − 1.7 (− 7.4, 3.9) | − 3.0 (− 9.3, 3.3) | − 0.1 (− 6.5, 6.4) | 1.4 (− 1.9, 4.6) | − 0.5 (− 6.8, 5.8) |
| 0–8.8 | 1.3 (− 3.7, 6.3) | 4.6 (0.8, 8.5)* | − 2.3 (− 9.8, 5.2) | − 4.9 (− 10.9, 1.1) | − 3.8 (− 10.5, 2.9) | − 2.2 (− 9.0, 4.7) | − 0.9 (− 4.3, 2.6) | 1.3 (− 5.4, 8.0) |
| p-trend | 0.46 | 0.005 | 1.00 | 0.20 | 0.40 | 0.94 | 0.89 | 0.93 |
| Device-measured sedentary time continuous (h/day)a,e | ||||||||
| 1 unit decrease | 0.5 (− 0.6, 1.5) | 1.2 (0.4, 2.0)* | 0.5 (− 1.1, 2.1) | 0.7 (− 1.9, 0.6) | − 0.3 (− 1.7, 1.0) | 0.2 (− 1.2, 1.7) | 0.2 (− 0.5, 0.9) | − 0.2 (− 1.6, 1.2) |
*p < 0.05
aModel is adjusted for age (years), sex (male, female), BMI (kg/m2), comorbidities (0, 1, ≥ 2), tumor stage (I, II, III), smoking status (never, former, current), education level (low, medium, high), and mobility limitation (yes, no)
bModel for device-measured MVPA is also adjusted for sedentary time (h/day)
c0–150 (n = 77), ≥ 150 (n = 264)
d0–150 (n = 40); ≥ 150 (n = 300)
eModel for sedentary time is also adjusted for MVPA (h/week)